Applied and Basic Research

Our Applied and Basic Research seeks to answers real-life questions pertaining to all levels of patient health across many fields of focus. We are continually conducting cutting-edge trials, making pivotal discoveries, and turning those findings into knowledge that will improve those suffering from respiratory illnesses, allergies and food allergies. 

Active Studies

Study Title (link to more info on this site)sort ascending Principal Investigator
Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD) Stefano Guerra , MD, PhD, MPH, Fernando Martinez, MD
Tucson Children's Respiratory Study (TCRS) Stefano Guerra , MD, PhD, MPH, Fernando Martinez, MD
TReating Children to Prevent EXacerbations of Asthma (TREXA) Fernando Martinez, MD, Wayne J. Morgan, MD
Steroids in Eosinophil Negative Asthma (SIENA) Fernando Martinez, MD
Sleep Intervention During Acute Lung Injury Tara F. Carr, MD, Sairam Parthasarathy, MD
Prevention of Early Asthma in Kids (PEAK)
Peer-Driven Intervention for Sleep Apnea (PCORI) Sairam Parthasarathy, MD
Pediatric Asthma Controller Trial (PACT)
Pathways to Immunologically Mediated Asthma (PIMA) Fernando Martinez, MD
Montelukast or Azithromycin for Reduction of Inhaled CorticoSteroids in Childhood Asthma (MARS)
Maintenance vs. Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
Infant Immune Study (IIS) Marilyn Halonen, PhD, Fernando Martinez, MD, Wayne J. Morgan, MD
Childhood Asthma Research and Education (CARE) Network
Characterizing the Response to a Leukotriene Receptor Antagonist and an Inhaled Corticosteroid (CLIC)
Best ADd-on Therapy Giving Effective Response (BADGER)
Acute Intervention Management Strategies (AIMS)
A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Lynn B. Gerald, PhD, MSPH
A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Lynn B. Gerald, PhD, MSPH